Gabriel Rebick

Gabriel Rebick

Auto-generated profile, based on publicly available information

Gabriel Rebick

New York University Grossman School of Medicine, Department of Medicine, New York, NY

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2014 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
JLJerome A. Leis
Jerome A. Leis
GRGabriel W. Rebick
Gabriel W. Rebick
NDNick Daneman
Nick Daneman
WGWayne L. Gold
Wayne L. Gold
Susan PoutanenSusan Poutanen
Susan Poutanen
AMAllison McGeer
Allison McGeer
This proof-of-concept study demonstrates that no longer routinely reporting urine culture results from noncatheterized medical and surgical inpatients can greatly reduce unnecessary antimicrobial therapy for asymptomatic bacteriuria without significant additional laboratory workload. Larger studies are needed to confirm the generalizability, safety, and sustainability of this model of care.

1 January 2013 in Journal of Ophthalmic Inflammation and Infection
Verified
Journal Article
Open access
PDF file
RHRoxane J Hillier
Roxane J Hillier
PAParnian Arjmand
Parnian Arjmand
GRGabriel Rebick
Gabriel Rebick
MOMario Ostrowski
Mario Ostrowski
RMRajeev H Muni
Rajeev H Muni
The emergence of antibiotic-resistant organisms among severe ocular infections is of grave concern. We describe the first reported case of vancomycin-resistant enterococcal endophthalmitis following ocular trauma, uniquely caused by Enterococcus gallinarum. The organism demonstrated intrinsic resistance to ceftazidime and vancomycin but responded favorably to a combination of intravitreal and intravenous ampicillin, plus intravitreal amikacin. When faced with a multidrug-resistant organism, the ophthalmologist must consider alternative antibiotic strategies.

12 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
SKSavannah Karmen-Tuohy
Savannah Karmen-Tuohy
PCPhilip M. Carlucci
Philip M. Carlucci
IZIoannis M. Zacharioudakis
Ioannis M. Zacharioudakis
FZFainareti N. Zervou
Fainareti N. Zervou
GRGabriel Rebick
Gabriel Rebick
JRJoseph Rahimian
Joseph Rahimian
Background: SARS-CoV-2 infection continues to cause significant morbidity and mortality worldwide. Preliminary data on SARS-CoV-2 infection suggests that some immunocompromised hosts experience worse outcomes. We performed a retrospective matched cohort study to characterize outcomes in HIV-positive patients with SARS-CoV-2 infection. Methods: Leveraging data collected from electronic medical records for all patients hospitalized at NYU Langone Health with COVID-19 between March 2, 2020 and April 23, 2020, we matched 21 HIV-positive patients to 42 non-HIV patients using a greedy nearest neighbor algorithm. Admission characteristics, laboratory results, and hospital outcomes were recorded and compared between the two groups. Results: While there was a trend toward increased rates of ICU admission, mechanical ventilation, and mortality in HIV-positive patients, these differences were not statistically significant. Rates for these outcomes in our cohort are similar to those previously published for all patients hospitalized with COVID-19. HIV-positive patients had significantly higher admission and peak CRP values. Other inflammatory markers did not differ significantly between groups, though HIV-positive patients tended to have higher peak values during their clinical course. Three HIV-positive patients had superimposed bacterial pneumonia with positive sputum cultures, and all three patients expired during hospitalization. There was no difference in frequency of thrombotic events or myocardial infarction between these groups. Conclusion: This study provides evidence that HIV coinfection does not significantly impact presentation, hospital course, or outcomes of patients infected with SARS-CoV-2, when compared to matched non-HIV patients. A larger study is required to determine if the trends we observed apply to all HIV-positive patients.

1 January 2013 in Canadian Journal of Infectious Diseases and Medical Microbiology
Verified
Journal Article
Open access
PDF file
AWAlanna Weisman
Alanna Weisman
GRGabriel Rebick
Gabriel Rebick
AMAndrew Morris
Andrew Morris
JBJagdish Butany
Jagdish Butany
WLW Conrad Liles
W Conrad Liles
An 80-year-old man living in Eastern Ontario was assessed at a local emergency department for a syncopal episode that occurred after awakening from sleep and ambulating to the bathroom. He had experienced malaise, anorexia and episodes of presyncope for four months. His medical history was significant for rheumatic fever in childhood without known cardiac sequelae, diverticulitis, hypertension and gastroesophageal reflux disease. A review of systems was notable for the absence of fever, weight loss, arthralgias, gastrointestinal (GI) and neurological complaints. The patient's medications were hydrochlorothiazide and rabeprazole. A transthoracic echocardiogram revealed a mobile mass on the aortic valve. There was no history of antimicrobial exposure within the preceding 12 months, and the patient denied illicit drug use, travel or exposure to animals. A physical examination revealed a systolic ejection murmur at the left upper sternal border. No stigmata of infective endocarditis (IE) were present. The remainder of the general examination was normal. A transesophageal echocardiogram revealed a 1.5 cm × 0.5 cm mobile mass on the right coronary cusp of the aortic valve and moderatesevere aortic insufficiency. Laboratory investigations were significant for normocytic anemia, with a hemoglobin level of 109 g/L and a serum albumin level of 39 g/L. The patient underwent mechanical aortic valve replacement for severe aortic insufficiency. Intraoperatively, the lesion appeared to be a vegetation of infectious origin, and valve specimens were sent for Gram stain and culture. Empirical antimicrobial therapy was initiated with ceftriaxone and vancomycin for presumed IE. Gross pathological examination revealed a thrombotic vegetation attached to the aortic valve. On high-power light microscopy, numerous small Gram-negative coccobacilli were observed along the margin of the vegetation, with no inflammatory cells present. Cultures from the valve and blood were negative after 21 days of incubation. Serologies for Bartonella henselae and Coxiella burnetii were negative. Broad-based 16S rDNA polymerase chain reaction (PCR)-based amplification and sequencing of the valvular tissue was requested through the Ontario Public Health Laboratory (Toronto, Ontario).

9 September 2008 in Canadian Medical Association Journal
Verified
Journal Article
Closed access
PDF file
GRGabriel Rebick
Gabriel Rebick
SMSuzanne Morin
Suzanne Morin
This patient presented with tachypnea and use of the inspiratory accessory muscles. Chest auscultation revealed diffusely decreased air entry bilaterally and early inspiratory rales. A chest radiograph showed hyperinflation and increased radiolucency of the lungs. The results of pulmonary function

19 February 2013 in Canadian Medical Association Journal
Verified
Journal Article
Open access
PDF file
GRGabriel W. Rebick
Gabriel W. Rebick
VAVanessa G. Allen
Vanessa G. Allen
WGWayne L. Gold
Wayne L. Gold
Chlamydia trachomatis and N. gonorrhoeae are the most common causes of urethritis in men. Other causes include Mycoplasma genitalium, Trichomonas vaginalis, Ureaplasma urealyticum and herpes simplex virus.1 Between 1997 and 2009, rates of gonococcal infections in Canada more than doubled to 33.1 cases per 100 000 population.2 Populations at highest risk of gonococcal infection include people with multiple sexual partners, men who have sex with men and people who have a history of sexually transmitted infection, all factors in this patient.1 The patient’s ongoing urethritis may be related to persistent gonococcal infection or to co-infection with a second untreated genitourinary pathogen. Because of the high risk of co-infection with C. trachomatis in patients with documented gonorrhea, Canadian guidelines recommend empiric treatment for chlamydia, even if results of chlamydia testing (not done for this patient) are negative.3